- This event has passed.
Events listed on BioOhio's Events Calendar are subject to change by the Event Organizer. Visit the organizer's website for current details.
Making Sense of the Current SPAC Market: Are SPACs still a viable pathway to going public?
June 9 @ 11:00 am - 12:00 pm
Within the past year the role in biotech of special purpose acquisition companies (SPAC) has moved from a rarefied interest to a core option for reaching ublic markets, now attracting high levels of investor and regulator attention.
Learn through live Q&A with a panel of SPAC deal experts how this popular, volatile tool for raising capital works in practice and will evolve next.
Moderated by: Barbara Ryan, Founder, Barbara Ryan Advisors; Editorial Advisory Board, Pharmaceutical Executive; Senior Advisor, EY
- Jonas Grossman, President and Managing Partner, Chardan
- Rakhi Kumar, Chief Accounting Officer, Roivant Sciences
- Ryan Maierson, Partner, Latham & Watkins LLP
- Carlo Passeri, Director, Biotechnology Capital Markets, Biotechnology Innovation Organization (BIO)